Cutaneous squamous cell carcinoma in the organ transplant recipient

Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H.L. Kurten; Charles B. Wessel; Heath Skinner; Dan P. Zandberg

doi:10.1016/j.oraloncology.2019.104562

Cutaneous squamous cell carcinoma in the organ transplant recipient

Kristin Bibee, Andrew Swartz, Shaum Sridharan, Cornelius H.L. Kurten, Charles B. Wessel, Heath Skinner, Dan P. Zandberg

Research output: Contribution to journal › Review article › peer-review

Abstract

One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal cutaneous carcinoma after transplantation. The majority of these cases develop on the head and neck and may require intervention on the part of dermatology, dermatologic surgery, otolaryngology, transplant medicine, radiation oncology, and medical oncology. In this review, we discuss the problem of cutaneous squamous cell carcinoma (cSCC) in SOTRs as well as the prognostic factors and management strategies to care for this population.

Original language	English (US)
Article number	104562
Journal	Oral Oncology
Volume	103
DOIs	https://doi.org/10.1016/j.oraloncology.2019.104562
State	Published - Apr 2020
Externally published	Yes

Keywords

Cutaneous head and neck cancer
Immunosuppression
Immunotherapy
Squamous cell carcinoma
Transplant

ASJC Scopus subject areas

Oral Surgery
Oncology
Cancer Research

Access to Document

10.1016/j.oraloncology.2019.104562

Cite this

@article{4e6e28ad81d743459778475a12636443,

title = "Cutaneous squamous cell carcinoma in the organ transplant recipient",

abstract = "One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal cutaneous carcinoma after transplantation. The majority of these cases develop on the head and neck and may require intervention on the part of dermatology, dermatologic surgery, otolaryngology, transplant medicine, radiation oncology, and medical oncology. In this review, we discuss the problem of cutaneous squamous cell carcinoma (cSCC) in SOTRs as well as the prognostic factors and management strategies to care for this population.",

keywords = "Cutaneous head and neck cancer, Immunosuppression, Immunotherapy, Squamous cell carcinoma, Transplant",

author = "Kristin Bibee and Andrew Swartz and Shaum Sridharan and Kurten, {Cornelius H.L.} and Wessel, {Charles B.} and Heath Skinner and Zandberg, {Dan P.}",

note = "Funding Information: C.H.L.K. was supported by the Programm zur internen Forschungsforderung Essen (IFORES). Funding Information: K.B. was supported by NIH/NCI T32 CA060397-20. Funding Information: K.B. was supported by NIH/NCI T32 CA060397-20. C.H.L.K. was supported by the Programm zur internen Forschungsforderung Essen (IFORES). Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = apr,

doi = "10.1016/j.oraloncology.2019.104562",

language = "English (US)",

volume = "103",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Cutaneous squamous cell carcinoma in the organ transplant recipient

AU - Bibee, Kristin

AU - Swartz, Andrew

AU - Sridharan, Shaum

AU - Kurten, Cornelius H.L.

AU - Wessel, Charles B.

AU - Skinner, Heath

AU - Zandberg, Dan P.

N1 - Funding Information: C.H.L.K. was supported by the Programm zur internen Forschungsforderung Essen (IFORES). Funding Information: K.B. was supported by NIH/NCI T32 CA060397-20. Funding Information: K.B. was supported by NIH/NCI T32 CA060397-20. C.H.L.K. was supported by the Programm zur internen Forschungsforderung Essen (IFORES). Publisher Copyright: © 2020 Elsevier Ltd

PY - 2020/4

Y1 - 2020/4

N2 - One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal cutaneous carcinoma after transplantation. The majority of these cases develop on the head and neck and may require intervention on the part of dermatology, dermatologic surgery, otolaryngology, transplant medicine, radiation oncology, and medical oncology. In this review, we discuss the problem of cutaneous squamous cell carcinoma (cSCC) in SOTRs as well as the prognostic factors and management strategies to care for this population.

AB - One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal cutaneous carcinoma after transplantation. The majority of these cases develop on the head and neck and may require intervention on the part of dermatology, dermatologic surgery, otolaryngology, transplant medicine, radiation oncology, and medical oncology. In this review, we discuss the problem of cutaneous squamous cell carcinoma (cSCC) in SOTRs as well as the prognostic factors and management strategies to care for this population.

KW - Cutaneous head and neck cancer

KW - Immunosuppression

KW - Immunotherapy

KW - Squamous cell carcinoma

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=85079394320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079394320&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2019.104562

DO - 10.1016/j.oraloncology.2019.104562

M3 - Review article

C2 - 32065978

AN - SCOPUS:85079394320

SN - 1368-8375

VL - 103

JO - Oral Oncology

JF - Oral Oncology

M1 - 104562

ER -

Cutaneous squamous cell carcinoma in the organ transplant recipient

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this